Back
Edgewise Therapeutics Vs. Catalyst Pharmaceuticals Industry Stock Comparison
Buy
90
EWTX
Edgewise Therapeutics
Last Price:
29.51
Seasonality Move:
-4.53%
Sell
49
CPRX
Catalyst Pharmaceuticals
Last Price:
21.34
Seasonality Move:
-9.09%
Buy
90
Edgewise Therapeutics (EWTX)
is a Buy
Is Edgewise Therapeutics a Buy, Sell or Hold?
- The current Edgewise Therapeutics [EWTX] share price is $29.50. The Score for EWTX is 90, which is 80% above its historic median score of 50, and infers lower risk than normal.
- EWTX is currently trading in the 80-90% percentile range relative to its historical Stock Score levels.
- This Score is currently showing an extreme reading that indicates risk levels may be considerably lower than normal.
Sell
49
Catalyst Pharmaceuticals (CPRX)
is a Sell
Is Catalyst Pharmaceuticals a Buy, Sell or Hold?
- The current Catalyst Pharmaceuticals [CPRX] share price is $21.36. The Score for CPRX is 49, which is 2% below its historic median score of 50, and infers higher risk than normal.
- CPRX is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
EWTX Stock Price Chart
What is Edgewise Therapeutics's stock price today?
-
The Edgewise Therapeutics share price today is $29.50
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and EWTX is experiencing buying pressure, which is a positive indicator for future bullish movement.
CPRX Stock Price Chart
What is Catalyst Pharmaceuticals's stock price today?
-
The Catalyst Pharmaceuticals share price today is $21.36
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and CPRX is experiencing buying pressure, which is a positive indicator for future bullish movement.
EWTX Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 0.79 | Buy |
Relative Strength Index (14 RSI): | 78.49 | Buy |
Chaikin Money Flow: | 9542700 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (16.59 - 21.35) | Buy |
Bollinger Bands (100): | (16.57 - 20.61) | Buy |
CPRX Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 0.5 | Buy |
Relative Strength Index (14 RSI): | 70.42 | Buy |
Chaikin Money Flow: | 901932 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (19.72 - 20.62) | Buy |
Bollinger Bands (100): | (15.22 - 19.16) | Buy |
EWTX Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 19.25 | Buy |
20-day SMA: | 18.87 | Buy |
50-day SMA: | 18.94 | Buy |
200-day SMA: | 16.56 | Buy |
8-day EMA: | 20.59 | Buy |
20-day EMA: | 19.2 | Buy |
50-day EMA: | 18.74 | Buy |
200-day EMA: | 16.34 | Buy |
CPRX Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 20.25 | Buy |
20-day SMA: | 20.17 | Buy |
50-day SMA: | 18.73 | Buy |
200-day SMA: | 16.16 | Buy |
8-day EMA: | 20.45 | Buy |
20-day EMA: | 20.02 | Buy |
50-day EMA: | 18.92 | Buy |
200-day EMA: | 16.55 | Buy |
Edgewise Therapeutics Earnings Growth & EWTX Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.03 per share, a decrease next quarter of $0.08 per share, an increase this year of $0.05 per share, and a decrease next year of $0.35 per share.
Catalyst Pharmaceuticals Earnings Growth & CPRX Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.06 per share, an increase next quarter of $0.10 per share, an increase this year of $0.05 per share, and an increase next year of $0.20 per share.
Edgewise Therapeutics Technical Analysis
Sep 6 | Sep 9 | Sep 10 | Sep 11 | Sep 12 | Sep 13 | Sep 16 | Sep 17 | Sep 18 | Sep 19 | |
---|---|---|---|---|---|---|---|---|---|---|
Sep | ||||||||||
06 | 09 | 10 | 11 | 12 | 13 | 16 | 17 | 18 | 19 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Catalyst Pharmaceuticals Technical Analysis
Sep 6 | Sep 9 | Sep 10 | Sep 11 | Sep 12 | Sep 13 | Sep 16 | Sep 17 | Sep 18 | Sep 19 | |
---|---|---|---|---|---|---|---|---|---|---|
Sep | ||||||||||
06 | 09 | 10 | 11 | 12 | 13 | 16 | 17 | 18 | 19 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |